CN Patent

CN115060824B — 一种瑞米吉泮中间体对映异构体杂质的液相色谱检测方法

Assigned to Zhejiang Hongyuan Pharmaceutical Co ltd · Expires 2024-03-12 · 2y expired

What this patent protects

本发明提供了一种快速方便、灵敏度高、准确性高、耐用性好的(R)‑9‑羟基‑6,7,8,9‑四氢‑5H‑环庚烷[b]吡啶‑5‑酮中对映异构体杂质(S)‑9‑羟基‑6,7,8,9‑四氢‑5H‑环庚烷[b]吡啶‑5‑酮含量的液相色谱检测方法。

USPTO Abstract

本发明提供了一种快速方便、灵敏度高、准确性高、耐用性好的(R)‑9‑羟基‑6,7,8,9‑四氢‑5H‑环庚烷[b]吡啶‑5‑酮中对映异构体杂质(S)‑9‑羟基‑6,7,8,9‑四氢‑5H‑环庚烷[b]吡啶‑5‑酮含量的液相色谱检测方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115060824B
Jurisdiction
CN
Classification
—
Expires
2024-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Hongyuan Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.